Jupiter Neurosciences, Inc.
JUNS Nasdaq
SEC CIK 1679628
Follow Jupiter Neurosciences
Weekly email: filings, results, news
Revenue, last quarter
$24.2K
Net income
−$2.3M
−1% vs same quarter last year
EPS, diluted
−$4.08
+19.8% vs same quarter last year
Operating cash flow
−$2.3M
−177.1% vs same quarter last year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY25 | −$8.6M |
| FY24 | −$2.4M |
| FY23 | −$4.8M |
| FY22 | - |
News
No stories filed under Jupiter Neurosciences yet - coverage appears here as the news feed clusters it.